Free Trial
NASDAQ:PRTC

PureTech Health (PRTC) Stock Price, News & Analysis

PureTech Health logo
$20.77
+0.61 (+3.03%)
(As of 10/29/2024 ET)

About PureTech Health Stock (NASDAQ:PRTC)

Key Stats

Today's Range
$20.49
$20.77
50-Day Range
$19.29
$25.00
52-Week Range
$17.08
$34.00
Volume
2,255 shs
Average Volume
4,051 shs
Market Capitalization
$497.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$45.00
Consensus Rating
Strong Buy

Company Overview

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. It also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; SPT-320, a novel prodrug of agomelatine for the treatment of generalized anxiety disorder; and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen for the treatment of mood and other neuropsychiatric disorders. In addition, the company is developing hydrogels to enable the oral administration of peptide therapeutics in preclinical development. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

PureTech Health Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
61st Percentile Overall Score

PRTC MarketRank™: 

PureTech Health scored higher than 61% of companies evaluated by MarketBeat, and ranked 470th out of 999 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    PureTech Health has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    PureTech Health has only been the subject of 2 research reports in the past 90 days.

  • Read more about PureTech Health's stock forecast and price target.
  • Earnings Growth

    Earnings for PureTech Health are expected to decrease in the coming year, from ($4.32) to ($5.16) per share.

  • Price to Book Value per Share Ratio

    PureTech Health has a P/B Ratio of 1.23. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.02% of the outstanding shares of PureTech Health have been sold short.
  • Short Interest Ratio / Days to Cover

    PureTech Health has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in PureTech Health has recently decreased by 24.29%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    PureTech Health does not currently pay a dividend.

  • Dividend Growth

    PureTech Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.02% of the outstanding shares of PureTech Health have been sold short.
  • Short Interest Ratio / Days to Cover

    PureTech Health has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in PureTech Health has recently decreased by 24.29%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    PureTech Health has a news sentiment score of 1.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for PureTech Health this week, compared to 1 article on an average week.
  • MarketBeat Follows

    3 people have added PureTech Health to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, PureTech Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.30% of the stock of PureTech Health is held by insiders.

  • Percentage Held by Institutions

    Only 0.04% of the stock of PureTech Health is held by institutions.

  • Read more about PureTech Health's insider trading history.
Receive PRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter.

PRTC Stock News Headlines

PureTech to Present at CHEST 2024 Annual Meeting
Watch this before it gets removed
If you missed it, my emergency election broadcast is now available - but will be removed soon
PureTech Health (PRTC) Gets a Buy from Leerink Partners
See More Headlines

PRTC Stock Analysis - Frequently Asked Questions

PureTech Health's stock was trading at $28.18 at the beginning of the year. Since then, PRTC shares have decreased by 26.3% and is now trading at $20.77.
View the best growth stocks for 2024 here
.

Shares of PRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that PureTech Health investors own include boohoo group (BOO), Cytokinetics (CYTK), Insmed (INSM), Super Micro Computer (SMCI), Arch Capital Group (ACGL), Adobe (ADBE) and Analog Devices (ADI).

Company Calendar

Today
10/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PRTC
Employees
100
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$45.00
High Stock Price Target
$45.00
Low Stock Price Target
$45.00
Potential Upside/Downside
+117.0%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.33 million
Book Value
$16.94 per share

Miscellaneous

Free Float
22,664,000
Market Cap
$496.31 million
Optionable
Not Optionable
Beta
1.18
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:PRTC) was last updated on 10/30/2024 by MarketBeat.com Staff
From Our Partners